van den Berk-Smeekens, Iris
van Dongen-Boomsma, Martine
De Korte, Manon W. P.
Den Boer, Jenny C.
Oosterling, Iris J.
Peters-Scheffer, Nienke C.
Buitelaar, Jan K. http://orcid.org/0000-0001-8288-7757
Barakova, Emilia I. http://orcid.org/0000-0001-5688-4878
Lourens, Tino
Staal, Wouter G.
Glennon, Jeffrey C.
Funding for this research was provided by:
ZonMw (Translational Research, project number 95103010)
Innovative Medicines Initiative (Joint Undertaking Grant No. 115300)
Karakter, expert center for the child- and adolescent psychiatry
Article History
Received: 29 November 2019
Accepted: 20 April 2020
First Online: 15 May 2020
Competing interests
: Jan K Buitelaar has been in the past three years a consultant to/member of the advisory board of/and/or speaker for Shire, Roche, Medice, Novartis and Servier. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, royalties. Other authors declare no competing financial and non-financial interests.